ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Start To Deploy Medidata Rave, Despite Contract Dispute

April 22, 2011

Cancer Screenings: American Over 50 Urged to Get Colon Caner Tests

March 5, 1999

IOM Appoints 17 To National Cancer Policy Board

February 7, 1997

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986